IDEAYA Biosciences IDYA
NASDAQ IDYA
$38.47 +0.61 (+1.61%)
As of: Sep 30, 2026 · 3:59 PM EDT

IDEAYA Biosciences (IDYA) Capital Expenditures (2018 - 2026)

Updated

IDEAYA Biosciences (IDYA) reported Capital Expenditures of $866,000 for Q2 2026, up 30.6% from $663,000 a year earlier but down 10.4% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Capital Expenditures (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, IDEAYA Biosciences' Capital Expenditures came in at $2.21 million, down 37.8% year-over-year; for FY2025, it was $2.37 million, down 38.6% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $3.86 million in FY2024 (+62.9%), $2.37 million in FY2023 (-31.2%), $3.44 million in FY2022 (+30.2%) and $2.64 million in FY2021 (+436.3%).
  • Five-year quarterly Capital Expenditures spans a low of $42,000 in Q3 2025 and a high of $1.94 million in Q2 2022.
  • Year over year, Capital Expenditures gained in three of the last eight quarters, with an average decline of 22.7%.
  • The high point for year-over-year Capital Expenditures in five years was Q4 2021 (growth of 238.0%); the low point was Q3 2025 (a decline of 90.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $967,000 (Q1 2026), $333,000 (Q4 2025) and $42,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 IDEAYA Biosciences 3.65 Bn 722.34 Mn - 866,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 866,000.00
Mar 31, 2026 967,000.00
Dec 31, 2025 333,000.00
Sep 30, 2025 42,000.00
Jun 30, 2025 663,000.00
Mar 31, 2025 1.33 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 457,000.00
Jun 30, 2024 973,000.00
Mar 31, 2024 1.33 Mn
Dec 31, 2023 838,000.00
Sep 30, 2023 603,000.00
Jun 30, 2023 884,000.00
Mar 31, 2023 43,000.00
Sep 30, 2022 1.10 Mn
Jun 30, 2022 1.94 Mn
Mar 31, 2022 401,000.00
Dec 31, 2021 605,000.00
Sep 30, 2021 458,000.00
Jun 30, 2021 578,000.00
API Access

IDEAYA Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IDYA&period=max&api_key=YOUR_API_KEY